4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001395064-22-000121
10% owner disposed of 5,750,000 shares (other)
- 10% owner acquired 5,750,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD 10% owner | 2022-07-01 | Other disposition | −5,750,000 | 0 | I | ||
| TAKEDA PHARMACEUTICAL CO LTD 10% owner | 2022-07-01 | Other acquisition | +5,750,000 | 5,750,000 | I | ||
| Derivatives | |||||||
| TAKEDA PHARMACEUTICAL CO LTD 10% owner | 2022-07-01 | Other disposition · Series A Convertible Preferred Stock | −1,250 | 0 | I | ||
| TAKEDA PHARMACEUTICAL CO LTD 10% owner | 2022-07-01 | Other acquisition · Series A Convertible Preferred Stock | +1,250 | 1,250 | I | ||
Loading xslF345X03/wf-form4_165710328185839.xml…